Advertisement
News
Advertisement

Aileron expands into endocrine, metabolic diseases

Thu, 09/06/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Aileron Therapeutics Inc., a Cambridge biotech founded five years ago to develop protein-based treatments for cancer, has announced it’s beginning a new program focused on drugs for endocrine and metabolic diseases.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading